Carlo Toniatti
The University of Texas MD Anderson Cancer Center · 225 works · 10,356 citations · h-index 49
Top works
- Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
- Co-occurring Genomic Alterations Define Major Subsets of KRAS -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
- Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans.
- The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
- Dual control of C‐reactive protein gene expression by interleukin‐1 and interleukin‐6.
- Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors
- Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice.
- Constitutive and IL‐6‐induced nuclear factors that interact with the human C‐reactive protein promoter.
- An inhibitor of oxidative phosphorylation exploits cancer vulnerability
- Two distinct and independent sites on IL‐6 trigger gp 130 dimer formation and signalling.
- Synergistic trans‐activation of the human C‐reactive protein promoter by transcription factor HNF‐1 binding at two distinct sites.
- Generation of interleukin‐6 receptor antagonists by molecular‐modeling guided mutagenesis of residues important for gp130 activation.
- Rational design of a receptor super‐antagonist of human interleukin‐6.
- Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
- Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells
- Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
- Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector
- The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
- Stringent Control of Gene Expression In Vivo by Using Novel Doxycycline-Dependent Trans -Activators
- Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors